A combination study, which measured serum levels of des-carboxyprothrombin (DCP) with AFP (LIMPULSE G1200, Fujirebio Inc., Tokyo, Japan), suggested that the association of AFP with DCP might be the best and most cost-effective strategy for monitoring patients for HCC [62]. The gene discussed is AFP; the disease is hepatocellular carcinoma.